Delivery Order SPE2DB20D2001-SPE2DB23FM67Q

Award Date 8/9/23
Potential Completion Date 8/10/23
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Latuda 40 mg tablets. The $19,603.20 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the company's parent organization, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,233.27 firm fixed-price delivery order covers the supply of 80 mg Latuda tablets to support military healthcare programs. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $8,299.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of Latuda 20 mg tablets, a specialty pharmaceutical product, to support military and federal healthcare programs. The contract has a period of performance through March 16, 2023 and was awarded on a firm-fixed price basis. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,137.66, is for the delivery of Latuda 20 mg tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract is a delivery order under an Indefinite Delivery Contract (IDC) between Cencora, Inc....
This Federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Latuda 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,437.51 and a period of performance through February 3, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,285.26 firm fixed-price delivery order is for the supply of the drug Latuda (40 mg tablet, 30 tablets per bottle) to support military and federal medical programs. The award is part of a $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Latuda 20 mg tablets. The contract, valued at $1,960.32, is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $4,994.14 firm-fixed-price delivery order (SPE2DB20D3111|SPE2DB23FB0EB) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4562215936 Latuda 40 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which was awarded by the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), for the drug Latuda 80 mg tablets. The firm fixed price contract has a ceiling value of $12,214.60 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,575.82 firm fixed-price delivery order contract is for the supply of Latuda 80 mg tablets to support federal healthcare programs. The contract is not designated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB23FM67Q
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Latuda 80 mg tablets. The $15,123.24 firm-fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a key vendor supporting the healthcare needs of U.S. military personnel, veterans, and other federal beneficiaries through its extensive pharmaceutical distribution capabilities and strategic contract vehicles with government agencies.

Generated 2/27/25, 10:02 AM